Oxford-based Brainomix agrees AI stroke care partnership with Blackford
Brainomix, an Oxford based AI-powered medtech solutions firm, has agreed a partnership with strategic imagining AI platform and solutions provider Blackford.
The partnership will bring Brainomix’s e-Stroke system to the Blackford Platform, improving the accessibility of its advanced stroke care technology globally.
Using AI, Brainomix’s system can generate interpretations of the more accessible non-contrast CT exams, making it easier to access treatments for strokes – particularly in more rural areas where access to advanced imaging is often more limited.
Read more - Ten South East healthtech companies to watch
"Timely diagnosis and treatment of stroke should not be limited to urban areas and comprehensive stroke centers,” said Blackford Founder and CEO Ben Panter. “Adding Brainomix’s AI-powered e-Stroke to the Blackford Platform allows more institutions around the world to accelerate transfer and treatment times and expand access to critical endovascular therapy for their patients.”
Brainomix’s software provides physicians with faster and more accurate analysis of images, making treatment decisions quicker. It also provides an app which can be used to access, review and share patient images and data, accelerating transfer and treatment decisions.
“We are very excited to launch this partnership with Blackford,” said Dr Michalis Papadakis, CEO & co-founder at Brainomix.
“With our e-Stroke platform, we believe that we have the opportunity to work together to provide physicians with the most comprehensive stroke AI imaging solution, shown to optimize networks and ultimately improve patient outcomes.”
Read more - Medtech partnership improving stroke outcomes